宿主与微生物血液宏基因组学揭示危重症表型的关键通路
该研究分析了两家医院前瞻性队列中113例低炎症脓毒症和76例高炎症脓毒症患者的血液宿主与微生物宏基因组测序数据,发现两表型有5755个基因(31%)差异表达,高炎症表型以先天免疫应答基因表达升高为主,低炎症表型以适应性免疫应答及T细胞应答基因表达升高为主。血浆宏基因组显示高炎症表型中肠杆菌科的存在和丰度增加。两表型与既往报道的ARDS转录亚型(反应型与无炎症型)及脓毒症SRS1-2存在显著重叠。对VANISH试验数据的分析提示,糖皮质激素可能对低炎症表型患者产生有害效应。
要点
- 高炎症与低炎症脓毒症表型间有5755个基因(31%)差异表达,高炎症表型先天免疫应答基因表达升高,低炎症表型适应性免疫及T细胞应答基因表达升高。
- 高炎症表型血浆中肠杆菌科细菌DNA的存在率和丰度增加,菌血症构成与低炎症表型不同。
- 两表型与既往ARDS转录亚型(反应型与无炎症型)及脓毒症SRS1-2存在显著重叠,提示跨研究表型具有一致性。
- VANISH试验数据分析提示,糖皮质激素可能对低炎症表型患者产生有害效应。
- 上述转录与宏基因组特征可能为脓毒症的精准治疗策略提供依据。
适用人群与场景
- 两家医院前瞻性队列中纳入的脓毒症患者,包括113例低炎症表型和76例高炎症表型;分子表型此前已通过潜在类别分析确定。
研究设计与关键结果
- 研究类型为对两家医院前瞻性队列的二次分析,样本量为113例低炎症脓毒症和76例高炎症脓毒症患者;表型由潜在类别分析预先确定。
- 高炎症与低炎症表型间有5755个基因(31%)差异表达;高炎症表型先天免疫应答基因表达升高,低炎症表型适应性免疫应答基因及T细胞应答基因表达升高。
- 血浆宏基因组分析显示两表型在菌血症患病率、细菌DNA丰度和组成上存在差异,高炎症表型中肠杆菌科的存在和丰度增加。
- 两表型与既往识别的ARDS转录亚型(反应型与无炎症型)及脓毒症SRS1-2存在显著重叠。
- 对VANISH试验数据的分析提示,糖皮质激素可能对低炎症表型患者产生有害效应。
证据类型、等级与局限
- 证据类型:对前瞻性队列的二次分析及对VANISH试验数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高炎症与低炎症表型具有不同的转录和宏基因组特征,可能用于精准治疗策略。
- 对VANISH试验数据的分析提示,糖皮质激素可能对低炎症表型患者产生有害效应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Two molecular phenotypes of sepsis and acute respiratory distress syndrome, termed hyperinflammatory and hypoinflammatory, have been consistently identified by latent class analysis in numerous cohorts, with widely divergent clinical outcomes and differential responses to some treatments; however, the key biological differences between these phenotypes remain poorly understood.Objectives: We used host and microbe metagenomic sequencing data from blood to deepen our understanding of biological differences between latent class analysis-derived phenotypes and to assess concordance between the latent class analysis-derived phenotypes and phenotypes reported by other investigative groups (e.g., Sepsis Response Signature [SRS1-2], molecular diagnosis and risk stratification of sepsis [MARS1-4], reactive and uninflamed).Methods: We analyzed data from 113 patients with hypoinflammatory sepsis and 76 patients with hyperinflammatory sepsis enrolled in a two-hospital prospective cohort study. Molecular phenotypes had been previously assigned using latent class analysis.Measurements and Main Results: The hyperinflammatory and hypoinflammatory phenotypes of sepsis had distinct gene expression signatures, with 5,755 genes (31%) differentially expressed. The hyperinflammatory phenotype was associated with elevated expression of innate immune response genes, whereas the hypoinflammatory phenotype was associated with elevated expression of adaptive immune response genes and, notably, T cell response genes. Plasma metagenomic analysis identified differences in prevalence of bacteremia, bacterial DNA abundance, and composition between the phenotypes, with an increased presence and abundance of Enterobacteriaceae in the hyperinflammatory phenotype. Significant overlap was observed between these phenotypes and previously identified transcriptional subtypes of acute respiratory distress syndrome (reactive and uninflamed) and sepsis (SRS1-2). Analysis of data from the VANISH trial indicated that corticosteroids might have a detrimental effect in patients with the hypoinflammatory phenotype.Conclusions: The hyperinflammatory and hypoinflammatory phenotypes have distinct transcriptional and metagenomic features that could be leveraged for precision treatment strategies.
参考来源
- Neyton LPA, Sinha P, Sarma A, et al. Host and Microbe Blood Metagenomics Reveals Key Pathways Characterizing Critical Illness Phenotypes. Am J Respir Crit Care Med. 2024. PMID: 38190719. doi:10.1164/rccm.202308-1328OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。